<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00710502</url>
  </required_header>
  <id_info>
    <org_study_id>05626</org_study_id>
    <nct_id>NCT00710502</nct_id>
  </id_info>
  <brief_title>Transvaginal NOTES Cholecystectomy: Phase I/II Mexico Clinical Trial</brief_title>
  <official_title>Transvaginal Natural Orifice Translumenal and Endoscopic Surgery (NOTES) Cholecystectomy vs. Laparoscopic Cholecystectomy: Phase I/II Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Ju√°rez del Estado de Durango</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>North Texas Veterans Healthcare System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cholecystectomy is one of the most common general surgery procedures performed in the US&#xD;
      today and is among top 10 procedures performed in U.S. hospitals annually, and biliary tract&#xD;
      disease has been estimated to cost U.S. healthcare $5 billion/year. Laparoscopic&#xD;
      cholecystectomy was introduced in the early 1990s and has become the standard surgical&#xD;
      approach for the treatment of gallbladder disease. More than 500,000 cholecystectomy&#xD;
      procedures are performed in the US every year. Laparoscopic cholecystectomy is now performed&#xD;
      as an outpatient basis and is related to a very low complication rate. Laparoscopic&#xD;
      cholecystectomy requires the use of multiple trocar incisions.&#xD;
&#xD;
      Natural Orifice Translumenal Endoscopic Surgery(NOTES) is a new type of surgical procedure&#xD;
      currently being studied around the world. The idea of NOTES was developed several years ago&#xD;
      in response to the concepts that patients would&#xD;
&#xD;
        1. realize the benefits of less invasive surgery by reducing the recovery time,&#xD;
&#xD;
        2. experience less physical discomfort associated with traditional procedures&#xD;
&#xD;
        3. have virtually no visible scarring following this type of surgery.&#xD;
&#xD;
      All of these advantages have spurred research and investigation forward, encouraging&#xD;
      physicians and researchers to develop new equipment and techniques to use during NOTES&#xD;
      procedures. Although the Natural Orifice Translumenal Endoscopic Surgery approach may hold&#xD;
      tremendous potential, there are many issues that need to be addressed before this technique&#xD;
      is introduced into clinical care.&#xD;
&#xD;
      The purpose of this study is to determine the safety, feasibility and short-term clinical&#xD;
      outcomes (Phase I trial) of transvaginal NOTES cholecystectomy in female patients with&#xD;
      symptomatic cholelithiasis and compare it to Laparoscopic Cholecystectomy (Phase II).&#xD;
&#xD;
      Hypothesis 1: Transvaginal NOTES cholecystectomy is safe and feasible in female patients with&#xD;
      symptomatic cholelithiasis.&#xD;
&#xD;
      Hypothesis 2: The short term outcomes of Transvaginal NOTES cholecystectomy are comparable to&#xD;
      Laparoscopic Cholecystectomy in female patients with symptomatic cholelithiasis.&#xD;
&#xD;
      Aim 1: Determine the safety of Transvaginal NOTES cholecystectomy. Aim 2: Determine the&#xD;
      feasibility of Transvaginal NOTES cholecystectomy. Aim 3: Determine the short-term outcomes&#xD;
      of Transvaginal NOTES cholecystectomy. Aim 4: Compare the short-term outcomes of Transvaginal&#xD;
      NOTES cholecystectomy to Laparoscopic cholecystectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Most recently, surgeons and endoscopists have focused on NOTES cholecystectomy. Access to the&#xD;
      abdominal cavity to perform NOTES procedures has been obtained by transgastric, transvaginal,&#xD;
      transvesical and transrectal approaches. The first successful NOTES procedure in humans was&#xD;
      an appendectomy in India. Transvaginal NOTES cholecystectomy has been successfully performed&#xD;
      and reported in a handful of cases in the US, Europe and South America. However, to date,&#xD;
      there is lack of clinical trials that demonstrate the safety and feasibility of Transvaginal&#xD;
      NOTES cholecystectomy in a larger group of patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety and Efficacy of Transvaginal NOTES cholecystectomy when compared to Laparoscopic cholecystectomy</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short term outcomes of Transvaginal NOTES cholecystectomy when compared to Laparoscopic Cholecystectomy</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cholelithiasis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transvaginal NOTES Cholecystectomy (Phase 1)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic Cholecystectomy (Phase 2)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transvaginal NOTES cholecystectomy (Phase 2)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transvaginal NOTES cholecystectomy</intervention_name>
    <description>Under general anesthesia, patients will undergo Transvaginal NOTES cholecystectomy</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <other_name>NOTES gallbladder removal</other_name>
    <other_name>NOTES gallbladder surgery</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic cholecystectomy</intervention_name>
    <description>Under general anesthesia, patients will undergo standard Laparoscopic cholecystectomy</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Small incision gallbladder surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult (&gt; 18 years old) female patients residents of Durango Mexico.&#xD;
&#xD;
          2. Patients who undergo elective surgery.&#xD;
&#xD;
          3. Patients with ultrasound documented symptomatic cholelithiasis, gallbladder polyps of&#xD;
             biliary dyskinesia.&#xD;
&#xD;
          4. Patients capable of giving written informed consent for the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who have contraindications prohibiting general anesthesia.&#xD;
&#xD;
          2. Pregnancy.&#xD;
&#xD;
          3. Previous abdominal or gynecological procedures.&#xD;
&#xD;
          4. Uncontrollable medical or psychiatric conditions&#xD;
&#xD;
          5. Elderly &gt; 65 y/o.&#xD;
&#xD;
          6. Body Mass Index &gt; 35 mg/kg2.&#xD;
&#xD;
          7. Complicated or acute cholecystitis.&#xD;
&#xD;
          8. Elevation of liver function tests.&#xD;
&#xD;
          9. Acute abdomen.&#xD;
&#xD;
         10. Intra-abdominal abscess.&#xD;
&#xD;
         11. Coagulopathy.&#xD;
&#xD;
         12. Imperforated hymen.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Homero Rivas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de la Paz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad Juarez del Estado de Durango, Mexico</name>
      <address>
        <city>Durango</city>
        <zip>34000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <study_first_submitted>July 2, 2008</study_first_submitted>
  <study_first_submitted_qc>July 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2008</study_first_posted>
  <last_update_submitted>December 14, 2009</last_update_submitted>
  <last_update_submitted_qc>December 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Homero Rivas MD</name_title>
    <organization>Hospital de la Paz</organization>
  </responsible_party>
  <keyword>Transvaginal</keyword>
  <keyword>NOTES</keyword>
  <keyword>Cholecystectomy</keyword>
  <keyword>Laparoscopic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

